Filtered By:
Specialty: Cardiology
Condition: Cardiogenic Shock
This page shows you your search results in order of date. This is page number 9.
Order by Relevance | Date
Total 235 results found since Jan 2013.
Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus
CONCLUSION: There is an increasing prevalence of DM in NVIE and it is associated with poorer outcomes. Further studies are crucial to identify the clinical, and sociodemographic contributors to this trend and develop strategies to mitigate its attendant risk.PMID:33552399 | PMC:PMC7821010 | DOI:10.4330/wjc.v13.i1.11
Source: World Journal of Cardiology - February 8, 2021 Category: Cardiology Authors: Temidayo Abe Harry Onoriode Eyituoyo Gabrielle De Allie Titilope Olanipekun Valery Sammah Effoe Kikelomo Olaosebikan Paul Mather Source Type: research
Clinical outcomes in patients with native valve infective endocarditis and diabetes mellitus.
CONCLUSION: There is an increasing prevalence of DM in NVIE and it is associated with poorer outcomes. Further studies are crucial to identify the clinical, and sociodemographic contributors to this trend and develop strategies to mitigate its attendant risk.
PMID: 33552399 [PubMed]
Source: World Journal of Cardiology - January 26, 2021 Category: Cardiology Authors: Abe T, Eyituoyo HO, De Allie G, Olanipekun T, Effoe VS, Olaosebikan K, Mather P Tags: World J Cardiol Source Type: research
Clinical features and outcomes between African American and Caucasian patients with Takotsubo Syndrome.
CONCLUSIONS: Despite experiencing the same rate of in-hospital complications, the clinical profiles of AA patients are distinct from CAU patients admitted for TS, and clinical variables correlated with worse in-hospital outcomes also differ by race.
PMID: 33427424 [PubMed - as supplied by publisher]
Source: Minerva Cardioangiologica - January 13, 2021 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research
Characteristics and Outcomes of Patients 80 Years and Older Hospitalized With Coronavirus Disease 2019 (COVID-19)
Patients older than 65 years hospitalized with COVID-19 have higher rates of intensive care unit admission and death when compared with younger patients. Cardiovascular conditions associated with COVID-19 include myocardial injury, acute myocarditis, cardiac arrhythmias, cardiomyopathies, cardiogenic shock, thromboembolic disease, and cardiac arrest. Few studies have described the clinical course of those at the upper extreme of age. We characterize the clinical course and outcomes of 73 patients with 80 years of age or older hospitalized at an academic center between March 15 and May 13, 2020. These patients had multiple ...
Source: Cardiology in Review - December 13, 2020 Category: Cardiology Tags: Review Articles Source Type: research
Predictors of Survival to Discharge After Successful Weaning From Venoarterial Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.
CONCLUSIONS: Complications that occurred during ECMO and the presence of extracardiac organ dysfunction after weaning were associated with in-hospital mortality in patients with cardiogenic shock who were successfully weaned off ECMO.
PMID: 33041291 [PubMed - as supplied by publisher]
Source: Circulation Journal - October 10, 2020 Category: Cardiology Authors: Kim D, Na SJ, Cho YH, Chung CR, Jeon K, Suh GY, Park TK, Lee JM, Song YB, Hahn JY, Choi JH, Choi SH, Gwon HC, Ahn JH, Carriere KC, Yang JH Tags: Circ J Source Type: research
Hemodynamic effects of ivabradine use in combination with intravenous inotropic therapy in advanced heart failure
AbstractIntravenous inotropic therapy can be used in patients with advanced heart failure, as palliative therapy or as a bridge to cardiac transplantation or mechanical circulatory support, as well as in cardiogenic shock. Their use is limited to increasing cardiac output in low cardiac output states and reducing ventricular filling pressures to alleviate patient symptoms and improve functional class. Many advanced heart failure patients have sinus tachycardia as a compensatory mechanism to maintain cardiac output. However, excessive sinus tachycardia caused by intravenous inotropes can increase myocardial oxygen consumpti...
Source: Heart Failure Reviews - September 29, 2020 Category: Cardiology Source Type: research
Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST-segment elevation at the National Institute of Cardiology (PHASE-MX).
Conclusion: In Mexico, only 5 out of 10 patients with STEMI have access to reperfusion therapy. Pharmacoinvasive strategy is takes advantage of the accessibility of fibrinolysis and the effectiveness of PCI. The present research protocol aims to provide information that serves as a link between information derived from controlled clinical trials and records derived from real world experience.
PMID: 32897264 [PubMed - as supplied by publisher]
Source: Archivos de Cardiologia de Mexico - September 9, 2020 Category: Cardiology Authors: Baeza-Herrera LA, Araiza-Garaygordobil D, Gopar-Nieto R, Raymundo-Martínez GI, Loáisiga-Sáenz A, Villalobos-Flores A, Martínez-Ramos M, Torres-Araujo LV, Pohls-Vázquez R, Luna-Herbert A, Alonso-Vázquez A, Delgado-Cruz IV, Cabello-López A, Martínez Tags: Arch Cardiol Mex Source Type: research
Evaluation of pharmacoinvasive strategy versus percutaneous coronary intervention in patients with acute myocardial infarction with ST segment elevation at the National Institute of Cardiology (PHASE-MX).
Conclusion: In Mexico, only 5 out of 10 patients with STEMI have access to reperfusion therapy. Pharmacoinvasive strategy is takes advantage of the accessibility of fibrinolysis and the effectiveness of PCI. The present research protocol aims to provide information that serves as a link between information derived from controlled clinical trials and records derived from real world experience.
PMID: 32459215 [PubMed - as supplied by publisher]
Source: Archivos de Cardiologia de Mexico - May 28, 2020 Category: Cardiology Authors: Baeza-Herrera LA, Araiza-Garaygordobil D, Gopar-Nieto R, Raymundo-Martínez GI, Loáisiga-Sáenz A, Villalobos-Flores A, Martínez-Ramos M, Torres-Araujo LV, Pohls-Vázquez R, Luna-Herbert A, Alonso-Vázquez A, Delgado-Cruz IV, Cabello-López A, Martínez Tags: Arch Cardiol Mex Source Type: research
Use of Administrative Claims to Assess Outcomes and Treatment Effect in Randomized Clinical Trials for Transcatheter Aortic Valve Replacement: Findings from the Extending Trial-Based Evaluations of Medical Therapies Using Novel Sources of Data (EXTEND) Study.
Conclusions: In the CoreValve HiR and SURTAVI trials, ascertainment of trial primary endpoints using claims reproduced both the magnitude and direction of treatment effect compared with adjudicated event data, but non-fatal and non-procedural secondary outcomes were not as well reproduced. Use of claims to substitute for adjudicated outcomes in traditional trial treatment comparisons may be valid and feasible for all-cause mortality and certain procedural outcomes, but may be less suitable for other endpoints.
PMID: 32436390 [PubMed - as supplied by publisher]
Source: Circulation - May 20, 2020 Category: Cardiology Authors: Strom JB, Faridi KF, Butala NM, Zhao Y, Tamez H, Valsdottir LR, Brennan JM, Shen C, Popma JJ, Kazi DS, Yeh RW Tags: Circulation Source Type: research
